Clean Science is that rare “studious topper” who doesn’t bunk classes, doesn’t do jugaad, and still manages to mint 40%+ operating margins while others in chemicals are just burning lab coats. Born in 2003, this Kurkumbh-based lab rat now sells anti-oxidants, UV blockers, pharma intermediates, and sunscreen raw materials across 35 countries. India imports chemicals, they export – matlab reverse UNO card.
2. Introduction
The Indian specialty chemicals industry has always had two types of players – those who smoke their margins faster than lab solvents, and those who build quiet monopolies. Clean Science is in the second category.
Imagine a company that sells “ingredients” nobody notices, but without which your cough syrup, sunscreen, sanitary pad, and even Maggi masala packet would cry. That’s Clean Science. It doesn’t scream “innovation” like Tesla, but quietly slips into 500+ global customers’ supply chains and refuses to leave.
But wait – it’s not all gyaan. Promoters are now doing a block deal to dump 24% stake (worth $302 million) at a discount. Family estate planning, they say. Investors call it “ghar ki safai.” Whatever the reason, the company still sits on fat R&D, low debt, and monopoly-style rankings (global no.1 or 2 in most products).
Do you think promoter stake sales = red flag, or just rich uncle’s family drama? Comment below.
3. Business Model (WTF Do They Even Do?)
Let’s simplify.
Performance Chemicals (69%): MEHQ, BHA, AP, TBHQ, HALS – basically fancy chemical names that stop your acrylic paints, plastics, and food oils from dying early. Think of them as preservatives for the non-edible world. HALS is the new rockstar here, replacing China imports.
Pharma & Agro Intermediates (19%): Guaiacol and DCC – critical to APIs (cough syrups, anti-retrovirals). India = world’s pharmacy, and these guys sell the raw masala.
FMCG Chemicals (12%): 4-MAP and Anisole – the hidden chemistry behind sunscreens and perfumes. If your crush smells good, thank Clean Science.
USP: Monopoly positions in niche products, low competition, backward integration, and a cleaner green chemistry process (less pollution = fewer inspectors drinking chai outside the factory gate).
Commentary: Clean Science margins are so thick (41–43%) that even HUL looks like a street-food vendor with 15% margin pav bhaji. But revenue growth is crawling like Mumbai traffic.
5. Valuation – Fair Value Range
We crunch three styles.
(a) P/E Method Industry avg P/E = 33. Clean = monopoly, so premium okay. Assume 35–42×. FV Range = 28.8 EPS × 35–42 = ₹1,008 – ₹1,210.
(b) EV/EBITDA FY25 EBITDA ~₹402 Cr. EV/EBITDA industry avg = 22–26×. Range = 402 × 22–26 = ₹8,844 – ₹10,452 Cr. Per Share = ₹835 – ₹988.
